A detailed history of Valley National Advisers Inc transactions in Exact Sciences Corp stock. As of the latest transaction made, Valley National Advisers Inc holds 478 shares of EXAS stock, worth $20,635. This represents 0.0% of its overall portfolio holdings.

Number of Shares
478
Previous 603 20.73%
Holding current value
$20,635
Previous $44,000 25.0%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 19, 2024

SELL
$56.27 - $73.77 $7,033 - $9,221
-125 Reduced 20.73%
478 $33,000
Q4 2023

Jan 25, 2024

SELL
$59.06 - $75.72 $10,040 - $12,872
-170 Reduced 21.99%
603 $44,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $11,605 - $17,431
176 Added 29.48%
773 $53,000
Q2 2023

Jul 31, 2023

SELL
$62.68 - $95.05 $2,507 - $3,802
-40 Reduced 6.28%
597 $57,000
Q1 2023

Apr 26, 2023

BUY
$47.19 - $70.77 $17,129 - $25,689
363 Added 132.48%
637 $42,000
Q4 2022

Jan 12, 2023

BUY
$30.35 - $53.15 $4,643 - $8,131
153 Added 126.45%
274 $18,000
Q3 2022

Nov 08, 2022

BUY
$31.97 - $49.37 $991 - $1,530
31 Added 34.44%
121 $4,000
Q2 2022

Jul 15, 2022

BUY
$35.61 - $76.23 $249 - $533
7 Added 8.43%
90 $4,000
Q1 2022

May 06, 2022

BUY
$57.56 - $82.54 $2,244 - $3,219
39 Added 88.64%
83 $6,000
Q3 2021

Nov 10, 2021

BUY
$90.24 - $124.05 $721 - $992
8 Added 22.22%
44 $4,000
Q2 2021

Aug 02, 2021

BUY
$93.66 - $139.27 $187 - $278
2 Added 5.88%
36 $4,000
Q1 2021

May 07, 2021

BUY
$116.57 - $155.01 $3,963 - $5,270
34 New
34 $4,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.64B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Valley National Advisers Inc Portfolio

Follow Valley National Advisers Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valley National Advisers Inc, based on Form 13F filings with the SEC.

News

Stay updated on Valley National Advisers Inc with notifications on news.